- Opin vísindi
- →
- IRIS
- →
- IRIS
- →
- Skoða verk
JavaScript is disabled for your browser. Some features of this site may not work without it.
| Titill: | BRN2 is a non-canonical melanoma tumor-suppressor |
| Höfundur: |
... 14 fleiri höfundar Sýna alla höfunda |
| Útgáfa: | 2021-06-17 |
| Tungumál: | Enska |
| Umfang: | 2013565 |
| Deild: | Faculty of Medicine |
| Birtist í: | Nature Communications; 12(1) |
| ISSN: | 2041-1723 |
| DOI: | 10.1038/s41467-021-23973-5 |
| Efnisorð: | Erfðafræði; Húðkrabbamein; Frumur; Cell proliferation/genetics; Genes, tumor suppressor; Gene Expression Regulation, Neoplastic/genetics; Skin Neoplasms/metabolism; Immunohistochemistry; Humans; Phosphatidylinositol 3-Kinases/metabolism; Proto-Oncogene Proteins B-raf/genetics; DNA Copy Number Variations; Gene Knockdown Techniques; Chromatin Immunoprecipitation; Microarray Analysis; Melanoma/genetics; Cell Proliferation/genetics; Genes, Tumor Suppressor; Skin Neoplasms/genetics; POU Domain Factors/genetics; Mice, Inbred C57BL; Mice, Transgenic; Disease Progression; Haploinsufficiency; PTEN Phosphohydrolase/genetics; Animals; Homeodomain Proteins/genetics; Cell Line, Tumor; Mice; RNA, Small Interfering; Microphthalmia-Associated Transcription Factor/metabolism; Mutation; Carcinogenesis/genetics; Cohort Studies; General Physics and Astronomy; General Chemistry; General Biochemistry,Genetics and Molecular Biology |
| URI: | https://hdl.handle.net/20.500.11815/2910 |
Tilvitnun:Hamm , M , Sohier , P , Petit , V , Raymond , J H , Delmas , V , Le Coz , M , Gesbert , F , Kenny , C , Aktary , Z , Pouteaux , M , Rambow , F , Sarasin , A , Charoenchon , N , Bellacosa , A , Sanchez-del-Campo , L , Mosteo , L , Lauss , M , Meijer , D , Steingrímsson , E , Jönsson , G B , Cornell , R A , Davidson , I , Goding , C R & Larue , L 2021 , ' BRN2 is a non-canonical melanoma tumor-suppressor ' , Nature Communications , vol. 12 , no. 1 , 3707 , pp. 3707 . https://doi.org/10.1038/s41467-021-23973-5
|
|
Útdráttur:While the major drivers of melanoma initiation, including activation of NRAS/BRAF and loss of PTEN or CDKN2A, have been identified, the role of key transcription factors that impose altered transcriptional states in response to deregulated signaling is not well understood. The POU domain transcription factor BRN2 is a key regulator of melanoma invasion, yet its role in melanoma initiation remains unknown. Here, in a BrafV600EPtenF/+ context, we show that BRN2 haplo-insufficiency promotes melanoma initiation and metastasis. However, metastatic colonization is less efficient in the absence of Brn2. Mechanistically, BRN2 directly induces PTEN expression and in consequence represses PI3K signaling. Moreover, MITF, a BRN2 target, represses PTEN transcription. Collectively, our results suggest that on a PTEN heterozygous background somatic deletion of one BRN2 allele and temporal regulation of the other allele elicits melanoma initiation and progression.
|
|
Athugasemdir:Publisher Copyright: © 2021, The Author(s).
|
|
Skrár
Þetta verk birtist í eftirfarandi safni/söfnum:
Verwandte Dokumente
Anzeige der Dokumente mit ähnlichem Titel, Autor, Urheber und Thema.
-
(2022-01-10)Thousands of non-coding variants have been associated with increased risk of human diseases, yet the causal variants and their mechanisms-of-action remain obscure. In an integrative study combining massively parallel reporter assays (MPRA), expression ... -
(2022-04-25)Objectives To find causal genes for rheumatoid arthritis (RA) and its seropositive (RF and/or ACPA positive) and seronegative subsets. Methods We performed a genome-wide association study (GWAS) of 31 313 RA cases (68% seropositive) and ∼1 million ...
-
(2021-01-30)Interleukin 6 (IL-6) is a multifunctional cytokine with both pro-A nd anti-inflammatory properties with a heritability estimate of up to 61%. The circulating levels of IL-6 in blood have been associated with an increased risk of complex disease ...